Istituto Clinico Humanitas


Mailand (Milano), Italy

Publications in cooperation with FAU scientists

Peyrin-Biroulet, L., Danese, S., Cummings, F., Atreya, R., Greveson, K., Pieper, B., & Kang, T. (2019). Anti-TNF biosimilars in Crohn's Disease: a patient-centric interdisciplinary approach. Expert Review of Gastroenterology and Hepatology.
Subramaniam, S., Hayee, B., Aepli, P., Schoon, E., Stefanovic, M., Kandiah, K.,... Bhandari, P. (2019). Optical diagnosis of colorectal polyps with Blue Light Imaging using a new international classification. United European Gastroenterology Journal, 7(2), 316-325.
Bailey, D.L., Pichler, B.J., Gueckel, B., Antoch, G., Barthel, H., Bhujwalla, Z.M.,... Beyer, T. (2018). Combined PET/MRI: Global Warming—Summary Report of the 6th International Workshop on PET/MRI, March 27–29, 2017, Tübingen, Germany. Molecular Imaging and Biology, 20(1), 4-20.
Pages, F., Mlecnik, B., Marliot, F., Bindea, G., Ou, F.-S., Bifulco, C.,... Galon, J. (2018). International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet, 391(10135), 2128-2139.
Fazio, N., Carnaghi, C., Buzzoni, R., Valle, J., Herbst, F., Ridolfi, A.,... Yao, J.C. (2018). Relationship between Metabolic Toxicity and Efficacy of Everolimus in Patients with Neuroendocrine Tumors (NETs): A Pooled Analysis from the Randomized, Phase 3 RADIANT-3 and RADIANT-4 Trials. (pp. 211-211).
Chan, D.L., Yao, J.C., Carnaghi, C., Buzzoni, R., Herbst, F., Ridolfi, A.,... Singh, S. (2018). Systemic Markers of Inflammation in Neuroendocrine Tumors (NETs) and Outcomes with Everolimus: A Pooled Analysis from the Randomized, Phase 3 RADIANT-3 and RADIANT-4 Trials. (pp. 151-151).
Perrino, C., Barabasi, A.-L., Condorelli, G., Davidson, S.M., De Windt, L., Dimmeler, S.,... Ferdinandy, P. (2017). Epigenomic and transcriptomic approaches in the post-genomic era: path to novel targets for diagnosis and therapy of the ischaemic heart? Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart. Cardiovascular Research, 113(7), 725-736.
Pavel, M.E., Singh, S., Strosberg, J.R., Bubuteishvili-Pacaud, L., Degtyarev, E., Neary, M.P.,... Yao, J.C. (2017). Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncology, 18(10), 1411-1422.
Buzzoni, R., Carnaghi, C., Strosberg, J., Fazio, N., Singh, S., Herbst, F.,... Pommier, R. (2017). Impact of prior therapies on everolimus activity: an exploratory analysis of RADIANT-4. Oncotargets and Therapy, 10, 5013-5030.
Elhai, M., Meune, C., Boubaya, M., Avouac, J., Hachulla, E., Balbir-Gurman, A.,... Allanore, Y. (2017). Mapping and predicting mortality from systemic sclerosis. Annals of the Rheumatic Diseases.
Ferreri, A.J.M., Cwynarski, K., Pulczynski, E., Fox, C.P., Schorb, E., La Rosee, P.,... Illerhaus, G. (2017). Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal L. Lancet Haematology, 4(11), e510-e523.
Genua, M., Becker, C., & Vetrano, S. (2016). Anti-TNF Antibodies and Autophagy: A Hidden Nexus for a Successful Therapeutic Response? Journal of Crohns & Colitis, 10(3), 237-8.
Ferreri, A.J.M., Cwynarski, K., Pulczynski, E., Ponzoni, M., Deckert, M., Politi, L.S.,... Illerhaus, G. (2016). Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. Lancet Haematology, 3(5), e217-27.
Ronchi, C.L., Peverelli, E., Herterich, S., Weigand, I., Mantovani, G., Schwarzmayr, T.,... Fassnacht, M. (2016). Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas. European Journal of Endocrinology, 174(3), 363-72.
Mahapatro, M., Försch, S., Hefele, M., He, G.-W., Giner-Ventura, E., Mchedlidze, T.,... Becker, C. (2016). Programming of Intestinal Epithelial Differentiation by IL-33 Derived from Pericryptal Fibroblasts in Response to Systemic Infection. Cell Reports, 15(8), 1743-56.
Lopez-Posadas, R., Becker, C., Günther, C., Tenzer, S., Amann, K.U., Billmeier, U.,... Atreya, I. (2016). The pseudokinase MLKL mediates programmed hepatocellular necrosis independently of RIPK3 during hepatitis. Journal of Clinical Investigation, 126(11), 4346-4360.
Apetoh, L., Smyth, M.J., Drake, C.G., Abastado, J.-P., Apte, R.N., Ayyoub, M.,... Anderson, A.C. (2015). Consensus nomenclature for CD8(+) T cell phenotypes in cancer. OncoImmunology, 4(4), e998538.
Roulis, M., Nikolaou, C., Kotsaki, E., Kaffe, E., Karagianni, N., Koliaraki, V.,... Kollias, G. (2014). Intestinal myofibroblast-specific Tpl2-Cox-2-PGE2 pathway links innate sensing to epithelial homeostasis. Proceedings of the National Academy of Sciences of the United States of America, 111(43), E4658-67.
Galon, J., Mlecnik, B., Bindea, G., Angell, H.K., Berger, A., Lagorce, C.,... Pages, F. (2014). Towards the introduction of the 'Immunoscore' in the classification of malignant tumours. Journal of Pathology, 232(2), 199-209.

Last updated on 2015-09-12 at 12:10

Share link